MedTrace Logo

Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App

NCT06301087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55618

Last updated 2024-03-15

No results posted yet for this study

Summary

The goal of this observational study is to confirm the impact of using this app adapted to be more specific for screening for 5 neurodevelopmental disorders and to evaluate the mothers' support program on the incidence of postpartum depression in of young parents with a minimum of 1 child under 10 years of age at the time of inclusion and using Malo on a regular basis. The main questions it aims to answer are :

* the median age of possible neurodevelopmental disorders notification of infants
* the median time of the mothers' postnatal depression notifications after childbirth subsequently to the support and prevention program Participants will agree with use of their data

Conditions

  • Development, Child
  • Postnatal Depression

Interventions

DEVICE

Web Application

web application for monitoring children's development and postnatal depression of mothers

Sponsors & Collaborators

  • Kelindi

    collaborator INDUSTRY

  • Weprom

    lead OTHER

Principal Investigators

  • Fabrice DENIS · Kelindi

Eligibility

Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2024-02-08
Completion
2024-02-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06301087 on ClinicalTrials.gov